Trial | NCT00567983  Report issue

Official Title

Topical Cyclosporine and Disease Progression

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    80
The purpose of this study is to evaluate the effect Restasis has in regards to disease progression.
Study Started
Dec 31
2007
Primary Completion
Sep 30
2008
Study Completion
Sep 30
2008
Last Update
Sep 25
2008
Estimate

Drug Restasis

Restasis- (in the eye) Instill one drop twice daily Endura- (in the eye) Instill one drop twice daily

Drug Endura

Restasis- (in the eye) Instill one drop twice daily Endura- (in the eye) Instill one drop twice daily

1. Active Comparator

2. Placebo Comparator

Criteria 

Inclusion Criteria:

Mild to Moderate dry eye symptoms

Exclusion Criteria:

Current use of Restasis
No Results Posted